Skip to main content

Mono Bar

Main Menu

Subsite Title

Publications and Digital Products

Cart

Store Navigation

Share Buttons

Page title

Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

Main page content

In stock for ordering

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Publication ID
SMA16-4938
Publication Date
March 2016
Format
More like this SAMHSA Advisory

Order Print Publication

Max Order Limit
25

Orders exceeding the maximum quantity limit require authorization.

You May Also Be Interested In

Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants

This Clinical Guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs

This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women.

Use of Medication-Assisted Treatment in Emergency Departments

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

The Facts about Buprenorphine for Treatment of Opioid Addiction

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders

This manual offers guidelines for medication-assisted treatment for people, particularly veterans, living with post-traumatic stress disorder and co-occurring opioid use disorders. It covers screening, concomitant treatment, pharmacotherapy, and multiple misused substances.

Behavioral Health Equity Barometer, 2014

This report provides a snapshot of key aspects of behavioral health, serious mental illness, suicidal thoughts, and mental illness, substance use disorders, or both. The information is based on selected determinants of health, including race and ethnicity, income level, geography, and health insurance status.